U.S. Physical Therapy, Inc. - 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for U.S. Physical Therapy, Inc. for the period ended June 30, 2004. The Company operates 254 outpatient physical and occupational therapy clinics across 35 states. During the first six months of 2004, the Company opened 16 new clinics. A significant corporate event occurred on July 6, 2004, with the resignation of Roy Spradlin as President, CEO, and Chairman; J. Livingston Kosberg serves as Interim CEO.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2004 | Six Months Ended June 30, 2003 |
|---|---|---|
| Net Revenues | $58.9 million | $52.0 million |
| Net Income | $3.8 million | $4.0 million |
| Diluted EPS | $0.31 | $0.33 |
| Operating Cash Flow | $9.3 million | $9.2 million |
| Cash and Equivalents | $21.9 million | $12.6 million |
| Total Debt | $0.2 million (Long-term notes only) | $2.4 million (Includes convertible note) |
| Current Ratio | 7.19:1 | 6.09:1 (Dec 31, 2003) |
Profitability: Operating income for the six months ended June 30, 2004, was $8.9 million, a slight decrease from $9.1 million in the prior year period. Clinic operating costs represented 71% of net revenues for the six-month period.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 13% year-over-year, driven by a 9% increase in patient visits (to 598,000) and a 4% increase in revenue per visit (to $96.44). New clinics opened in the last 12 months contributed approximately 56% of the revenue increase.
- Net Income Decline: Despite revenue growth, net income decreased 5% to $3.8 million. This was primarily due to a $717,000 charge for severance and recruiting costs related to the CEO resignation, increased corporate office costs (up 31%), and higher minority interest distributions.
- Debt Elimination: The Company converted the remaining $1.7 million of its Series C Convertible Subordinated Note into common stock on June 30, 2004, resulting in a debt-to-equity ratio of 0.0.
- Asset Sale: The Company recorded a gain of $441,000 on the sale of a clinic's assets on June 30, 2004.
Guidance, Outlook, and Risks
- Development Strategy: Following the CEO resignation, the Company is refocusing on traditional partner arrangements. The goal for 2004 is to open between 38 and 43 clinics, a reduction from the previously projected 45 to 50.
- Cost Outlook: The Company expects to incur an additional $250,000 to $350,000 in the second half of 2004 for recruiting, severance, and relocation costs associated with the CEO search.
- Medicare Limit Risk: Approximately 21% of revenues are derived from Medicare. A moratorium on the $1,590 annual reimbursement limit is in place through 2005. If the moratorium is not extended after 2005, the limit could adversely impact future revenue and income.
- Liquidity: Management believes cash and cash equivalents ($21.9 million) are sufficient to fund operations and development through at least 2005 without external credit lines.
Investor Verification Checklist
- Verify the impact of the $717,000 CEO severance charge on future corporate expense projections.
- Confirm the status of the search for a permanent CEO and associated timeline.
- Monitor the moratorium status on the Medicare reimbursement limit ($1,590) for 2006 and beyond.
- Review the performance of the 16 new clinics opened in the first half of 2004 to assess if they meet historical ramp-up expectations.
- Assess the sustainability of the 13% revenue growth rate given the reduced clinic opening targets for the remainder of 2004.